VIRUFLEX
Abstract
Manufacturing and processing pharmaceutical products, medical and veterinary preparations, preparations for vaccines, vaccines, in particular viral vaccines, adjuvants and additives for vaccines as well as adjuvants intended for use with vaccines, to order and according to customer requirements; Pharmaceutical products, namely, pharmaceutical preparations for the treatment of human immune system or infectious diseases and conditions; medical and veterinary preparations namely, diagnostic preparations for medical and veterinary purposes; medical and veterinary preparations namely, preparations for the prevention and treatment of malignant, infectious, and autoimmune disorders, diseases, and conditions for medical and veterinary purposes; preparations for vaccines; vaccines, in particular viral vaccines; adjuvants and additives for vaccines, namely, vaccine adjuvants and vaccine stabilizers; additives for vaccines, namely, vaccine stabilizers; Scientific and technological services, namely, scientific analysis and testing in the field of vaccines; scientific research and design services relating to vaccines; design and development of computer software; research and development services relating to vaccines; Software as a Service (SaaS) featuring software for analyzing and engineering of viral genomes
Filing Date
2023-12-19